title: Can urinary nerve growth factor be a biomarker for overactive bladder?
abstract: The clinical diagnosis of overactive bladder (OAB) greatly varies and is based on subjective symptoms. A more objective method to diagnose and assess therapeutic outcome in OAB patients, especially for health care providers not trained in urology, needs to be found. Evidence has shown that urinary proteins such as nerve growth factor (NGF) and prostaglandin E(2) levels increase in patients with OAB, bladder outlet obstruction, and detrusor overactivity. Urinary NGF level increases physiologically in normal subjects at urge to void, but increases pathologically in OAB patients at a small bladder volume and with a sensation of urgency. Recent studies have shown that patients with OAB dry and OAB wet have significantly higher urinary NGF levels compared with control groups and patients with increased bladder sensation. Urinary NGF levels decrease after antimuscarinic therapy and further decrease after detrusor botulinum toxin injections in refractory OAB. Urinary NGF level could be a potential biomarker for diagnosis of OAB and assessment of the therapeutic effect of antimuscarinic therapy. The latest medical advances in this field are reviewed herein.
authors.forename: Hann-Chorng
authors.initials: HC
authors.lastname: Kuo
authors.forename: Hsin-Tzu
authors.initials: HT
authors.lastname: Liu
authors.forename: Michael B
authors.initials: MB
authors.lastname: Chancellor
references.citation: BJU Int. 2008 Nov;102(10):1440-4
references.pmid: 18489524
references.citation: J Neurosci. 2006 Oct 18;26(42):10847-55
references.pmid: 17050722
references.citation: Urology. 2008 Jul;72(1):104-8; discussion 108
references.pmid: 18400272
references.citation: J Urol. 2006 Jan;175(1):191-4; discussion 194-5
references.pmid: 16406907
references.citation: J Urol. 2006 Jul;176(1):177-85
references.pmid: 16753396
references.citation: Neurourol Urodyn. 2001;20(3):249-57
references.pmid: 11385691
references.citation: Rev Urol. 2002;4 Suppl 4:S7-S18
references.pmid: 16986023
references.citation: Prog Brain Res. 2006;152:245-63
references.pmid: 16198705
references.citation: Am J Pathol. 1999 Oct;155(4):1183-93
references.pmid: 10514401
references.citation: Eur Urol. 2006 Aug;50(2):333-8
references.pmid: 16713066
references.citation: Nat Clin Pract Urol. 2006 Feb;3(2):101-10
references.pmid: 16470209
references.citation: J Urol. 2001 Sep;166(3):1111-8
references.pmid: 11490308
references.citation: J Urol. 2005 Aug;174(2):604-7
references.pmid: 16006914
references.citation: J Urol. 2006 Jun;175(6):2341-4
references.pmid: 16697870
references.citation: J Pain. 2004 Apr;5(3):150-6
references.pmid: 15106127
references.citation: Urology. 2005 Jul;66(1):94-8
references.pmid: 15992869
references.citation: J Urol. 2005 Sep;174(3):984-9
references.pmid: 16094019
references.citation: J Urol. 2005 Sep;174(3):977-82; discussion 982-3
references.pmid: 16094018
references.citation: Eur Urol. 2006 Oct;50(4):684-709; discussion 709-10
references.pmid: 16934391
references.citation: Urology. 2007 Sep;70(3):463-8
references.pmid: 17905097
references.citation: Prog Brain Res. 2006;152:97-115
references.pmid: 16198696
references.citation: Eur Urol. 2004 Apr;45(4):510-5
references.pmid: 15041117
references.citation: J Urol. 2001 Aug;166(2):550-2; discussion 553
references.pmid: 11458066
references.citation: J Urol. 2008 Jun;179(6):2270-4
references.pmid: 18423678
references.citation: BMC Physiol. 2007 Aug 28;7:9
references.pmid: 17725832
references.citation: J Urol. 2002 Nov;168(5):2269-74
references.pmid: 12394773
references.citation: Prog Neurobiol. 1999 Apr;57(6):583-606
references.pmid: 10221783
references.citation: J Clin Invest. 1991 Nov;88(5):1709-15
references.pmid: 1939656
references.citation: Neurourol Urodyn. 2007;26(3):405-9
references.pmid: 17266135
references.citation: Eur Urol. 2006 Apr;49(4):644-50
references.pmid: 16426734
references.citation: BJU Int. 2003 Nov;92(7):731-5
references.pmid: 14616456
references.citation: J Auton Nerv Syst. 1994 Oct;49(2):147-58
references.pmid: 7806767
references.citation: Br J Urol. 1997 Apr;79(4):572-7
references.pmid: 9126085
references.citation: Am J Physiol. 1999 Sep;277(3):R786-94
references.pmid: 10484496
references.citation: Neurourol Urodyn. 2003;22(7):638-42
references.pmid: 14595606
references.citation: Urology. 2004 May;63(5):868-72
references.pmid: 15134967
references.citation: Am J Obstet Gynecol. 2005 May;192(5):1735-40
references.pmid: 15902187
references.citation: J Urol. 1997 Feb;157(2):600-3
references.pmid: 8996367
references.citation: Eur Urol. 2009 Oct;56(4):700-6
references.pmid: 18472208
references.citation: Am J Manag Care. 2000 Jul;6(11 Suppl):S580-90
references.pmid: 11183901
references.citation: Exp Neurol. 2000 Jan;161(1):273-84
references.pmid: 10683293
references.citation: BJU Int. 2007 Jun;99(6):1439-42
references.pmid: 17419703
references.citation: Obstet Gynecol. 2004 Dec;104(6):1263-9
references.pmid: 15572487
references.citation: Neurourol Urodyn. 2008;27(5):417-20
references.pmid: 17924444
references.citation: Neurourol Urodyn. 2003;22(2):105-8
references.pmid: 12579626
references.citation: J Urol. 2006 May;175(5):1773-6; discussion 1776
references.pmid: 16600756
references.citation: BJU Int. 2009 Jun;103(12):1668-72
references.pmid: 19220267
references.citation: J Urol. 2004 Jan;171(1):478-82
references.pmid: 14665959
references.citation: J Urol. 1999 Feb;161(2):438-41; discussion 441-2
references.pmid: 9915421